Abstract
BACKGROUND: Response to induction chemotherapy (IC) has been predicted in patients with sinonasal cancer using early delta radiomics obtained from T1- and T2-weighted images and apparent diffusion coefficient (ADC) maps, comparing results with early radiological evaluation by RECIST. METHODS: Fifty patients were included in the study. For each image (at baseline and after the first IC cycle), 536 radiomic features were extracted as follows: semi-supervised principal component analysis components, explaining 97% of the variance, were used together with a support vector machine (SVM) to develop a radiomic signature. One signature was developed for each sequence (T1-, T2-weighted and ADC). A multiagent decision-making algorithm was used to merge multiple signatures into one score. RESULTS: The area under the curve (AUC) for mono-modality signatures was 0.79 (CI: 0.65-0.88), 0.76 (CI: 0.62-0.87) and 0.93 (CI: 0.75-1) using T1-, T2-weighted and ADC images, respectively. The fuse signature improved the AUC when an ADC-based signature was added. Radiological prediction using RECIST criteria reached an accuracy of 0.78. CONCLUSIONS: These results suggest the importance of early delta radiomics and of ADC maps to predict the response to IC in sinonasal cancers.